Laurie Toich, Associate Editor

Conflicting breast cancer treatment guidelines can leave many decisions to the discretion of the provider.

Investigational JAK1-selective inhibitor may reduce the symptoms of atopic dermatitis.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Cisplatin and platinum-based chemotherapies cause hearing loss in up to 80% of adults and more than 50% of children.

One daily serving of leafy green vegetables slowed decline in performance on thinking and memory tests.

Unapproved stem cell therapies may cause patient harm with serious and life-threatening diseases.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Despite the benefits of oral oncolytics, high out-of-pocket costs could put treatment out of reach for patients with cancer.

A small number of liquid biopsy test results from different providers matched for overlapping genetic sequences.

Treatment with upadacitinib resulted in reduced disease activity and clinical remission in patients with rheumatoid arthritis.

Older patients may have cellular damage that reduces the body’s response to the flu virus.

Providing information about breast cancer surgery via an online tool may help patients feel more informed about their treatment options.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

A new report highlights the potential pitfalls of formulary exclusion lists used by pharmacy benefit managers.

Daratumumab combination therapy tripled the minimal residual disease negativity rate among patients with multiple myeloma.

More than one-third of metformin doses are not taken by patients with type 2 diabetes.

The Maraba virus was observed to kill latently infected HIV cells.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.